113 related articles for article (PubMed ID: 10499425)
1. Synthesis and binding characteristics of [3H] H-Tyr-Ticpsi[CH2-NH] Cha-Phe-OH, a highly specific and stable delta-opioid antagonist.
Szatmári I; Tóth G; Kertész I; Schiller PW; Borsodi A
Peptides; 1999; 20(9):1079-83. PubMed ID: 10499425
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist.
Nevin ST; Tóth G; Weltrowska G; Schiller PW; Borsodi A
Life Sci; 1995; 56(10):PL225-30. PubMed ID: 7885186
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP.
Nevin ST; Toth G; Nguyen TM; Schiller PW; Borsodi A
Life Sci; 1993; 53(5):PL57-62. PubMed ID: 8393120
[TBL] [Abstract][Full Text] [Related]
4. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1993 Oct; 36(21):3182-7. PubMed ID: 8230106
[TBL] [Abstract][Full Text] [Related]
5. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
[TBL] [Abstract][Full Text] [Related]
6. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
7. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
[TBL] [Abstract][Full Text] [Related]
8. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
Schiller PW; Fundytus ME; Merovitz L; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Coderre TJ
J Med Chem; 1999 Sep; 42(18):3520-6. PubMed ID: 10479285
[TBL] [Abstract][Full Text] [Related]
9. A chimeric opioid peptide with mixed mu agonist/delta antagonist properties.
Weltrowska G; Lemieux C; Chung NN; Schiller PW
J Pept Res; 2004 Feb; 63(2):63-8. PubMed ID: 15009527
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
11. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
[TBL] [Abstract][Full Text] [Related]
12. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
13. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive study on the putative δ-opioid receptor (sub)types using the highly selective δ-antagonist, Tyr-Tic-(2S,3R)-β-MePhe-Phe-OH.
Birkas E; Bakota L; Gulya K; Wen T; Pintar J; Tóth G; Szucs M
Neurochem Int; 2011 Aug; 59(2):192-201. PubMed ID: 21672586
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors.
Maeda DY; Berman F; Murray TF; Aldrich JV
J Med Chem; 2000 Dec; 43(26):5044-9. PubMed ID: 11150176
[TBL] [Abstract][Full Text] [Related]
17. Characterization of N,N(Me)2-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist.
Monory K; Bryant SD; Kertész I; Balboni G; Guerrini R; Tóth G; Salvadori S; Lazarus LH; Borsodi A
Neuroreport; 2000 Jul; 11(10):2083-6. PubMed ID: 10923648
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and binding characteristics of the highly delta-specific new tritiated opioid peptide, [3H]deltorphin II.
Búzás B; Tóth G; Cavagnero S; Hruby VJ; Borsodi A
Life Sci; 1992; 50(14):PL75-8. PubMed ID: 1313131
[TBL] [Abstract][Full Text] [Related]
19. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.
Turchan J; Przewłocka B; Toth G; Lasoń W; Borsodi A; Przewłocki R
Neuroscience; 1999; 91(3):971-7. PubMed ID: 10391475
[TBL] [Abstract][Full Text] [Related]
20. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
